Avanafil — Discount Pricing
Avanafil is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Avanafil Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $62.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Avanafil
Avanafil is a prescription medication. Ask your doctor if Avanafil is right for you.
How to Check Avanafil Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Avanafil at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Urology
What Avanafil is approved for (FDA label)
Avanafil tablets are a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction in adult males. Avanafil tablet is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction ( 1 )
Source: Read the full FDA label on DailyMed. Label effective date: December 17, 2025.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Dosage forms and strengths for Avanafil (FDA label)
Avanafil tablets, 50 mg are white to off-white, oval shape, biconvex tablets debossed with ‘A41’ on one side and ‘H’ on the other side. Avanafil tablets, 100 mg are white to off-white, oval shape, biconvex tablets debossed with ‘A42’ on one side and ‘H’ on the other side. Avanafil tablets, 200 mg are white to off-white, oval shape, biconvex tablets debossed with ‘A43’ on one side and ‘H’ on the other side. Tablets: 50 mg, 100 mg, 200 mg ( 3 )
Source: FDA prescribing information (DailyMed). Set ID: 1d04e17d-7399-430a-a8bb-fa1912b155e9. SPL document ID: 46258a47-8730-8397-e063-6394a90a6478. Label effective date: December 17, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Avanafil (FDA label)
Most common adverse reactions (greater than or equal to 2%) include headache, flushing, nasal congestion, nasopharyngitis, and back pain ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Hetero Labs Limited at 1-866-495-1995 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. Avanafil was administered to 2215 men during clinical trials.
Source: FDA prescribing information (DailyMed). Set ID: 1d04e17d-7399-430a-a8bb-fa1912b155e9. SPL document ID: 46258a47-8730-8397-e063-6394a90a6478. Label effective date: December 17, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Avanafil (FDA label)
• Administration of avanafil tablet to patients using any form of organic nitrate is contraindicated ( 4.1 ) • Hypersensitivity to any component of the avanafil tablet ( 4.2 ) • Administration with guanylate cyclase (GC) stimulators such as riociguat and vericiguat ( 4.3 ) 4.1 Nitrates Administration of avanafil tablets with any form of organic nitrates, either regularly and/or intermittently, is contraindicated. Consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cGMP) pathway, avanafil has been shown to potentiate the hypotensive effects of nitrates. In a patient who has taken avanafil tablets, where nitrate administration is deemed medically necessary in a life-threatening situation, at least 12 hours should elapse after the last dose of avanafil tablets before nitrate administration is considered.
Source: FDA prescribing information (DailyMed). Set ID: 1d04e17d-7399-430a-a8bb-fa1912b155e9. SPL document ID: 46258a47-8730-8397-e063-6394a90a6478. Label effective date: December 17, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Warnings and precautions for Avanafil (FDA label)
Evaluation of erectile dysfunction (ED) should include an appropriate medical assessment to identify potential underlying causes, as well as treatment options. Before prescribing avanafil, it is important to note the following: • Patients should not use avanafil if sexual activity is inadvisable due to cardiovascular status or any other reason ( 5.1 ) • Use of avanafil with alpha-blockers, other antihypertensives, or substantial amounts of alcohol (greater than 3 units) may lead to hypotension ( 2.3 , 5.6 , 5.7 ) • Patients should seek emergency treatment if an erection lasts greater than 4 hours ( 5.3 ) • Patients should stop avanafil and seek medical care if a sudden loss of vision occurs in one or both eyes, which could be a sign of Non Arteritic Ischemic Optic Neuropathy (NAION).
Source: FDA prescribing information (DailyMed). Set ID: 1d04e17d-7399-430a-a8bb-fa1912b155e9. SPL document ID: 46258a47-8730-8397-e063-6394a90a6478. Label effective date: December 17, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Drug interactions for Avanafil (FDA label)
• Avanafil can potentiate the hypotensive effect of nitrates, alpha-blockers, antihypertensives, and alcohol ( 7.1 ) • CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, erythromycin) increase avanafil exposure ( 7.2 ) 7.1 Potential for Pharmacodynamic Interactions with Avanafil Nitrates Administration of avanafil to patients who are using any form of organic nitrate, is contraindicated. In a clinical pharmacology trial, avanafil was shown to potentiate the hypotensive effect of nitrates. In a patient who has taken avanafil, where nitrate administration is deemed medically necessary in a life-threatening situation, at least 12 hours should elapse after the last dose of avanafil before nitrate administration is considered. In such circumstances, nitrates should only be administered under close medical supervision with appropriate hemodynamic monitoring [see Contraindications ( 4.1 ), Dosage and Administration ( 2.3 ), and Clinical Pharmacology ( 12.2 )]. Alpha-Blockers Caution is advised when PDE5 inhibitors are co-administered with alpha-blockers.
Source: FDA prescribing information (DailyMed). Set ID: 1d04e17d-7399-430a-a8bb-fa1912b155e9. SPL document ID: 46258a47-8730-8397-e063-6394a90a6478. Label effective date: December 17, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.